Tag

2 results found for: NHS budget

What's the cost of NHS savings?

NHS England’s review of “low value” prescription items has the potential to save up to £400 million a year, but what could be the implications?

Reasons to welcome the prescribing review

What’s been happening under cover with prescribing is now out in the open, says Noel Wicks It seems that NHS England is taking a leaf out of the book of certain CCGs with its recent announcement to review a selection of “low value” medicines that it believes may have limited clinical value. The 10 items include tadalafil, travel vaccines, lidocaine plasters, fentanyl and doxazosin. In total, this could yield about £130 million in savings, although I imagine this assumes that no alternatives are prescribed. This seems a far cry from the £400 million that Simon Stevens suggested could be saved by this review. So where is the rest coming from? Alongside this initial list of specified medicines NHS England also intends review other areas such as gluten-free foods and minor ailments including hayfever, pain and indigestion.

Latest News

PSNC reassures contractors on flu vaccine stock levels

PSNC has issued a statement to reassure contractors that stocks are still available through the pharmacy wholesaler mar...

PSNC signals start of planning for DH negotiations

Work has begun in preparation for negotiations with the DH for 2018/19 on pharmacy funding, PSNC has said

Views

Rules, regulations and sanctions

Proposed legislation will safeguard pharmacy professionals from prosecution and bring an approach that is more unified w...

Popular Features

SCR cuts burden on NHS

Increasing the amount of information held in electronic summary care records is improving care and helping to ease winte...

Health body drive to reach more with flu jab

Public health bodies have teamed up to launch a raft of measures aimed at boosting flu jab uptake – including addressi...

Brine joins NHS execs in supporting Smokefree Pledge

Pharmacy minister Steve Brine has joined NHS England and Public Health England chief executives in endorsing the NHS Smo...